Topic

Tepezza (teprotumumab)

A collection of 33 issues

How to Get Tepezza (Teprotumumab) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Aetna CVS Health covers Tepezza for moderate-to-severe thyroid eye disease in Virginia with mandatory prior authorization requiring ophthalmologist evaluation, Clinical Activity Score ≥4, and documented steroid failure. Submit PA through CVS Specialty Pharmacy coordination. If denied, Virginia's Bureau of Insurance offers external review within 120 days

Do You Qualify for Tepezza Coverage by Humana in New York? Decision Tree & Appeals Guide

Answer Box: Your Fastest Path to Approval If you have thyroid eye disease (TED) with Clinical Activity Score ≥4, documented proptosis, and are euthyroid, Humana likely covers Tepezza under Medicare Part B with prior authorization. Submit through your ophthalmologist with complete documentation including CAS assessment, thyroid labs, and prior steroid

How to Get Tepezza (Teprotumumab) Approved by Aetna CVS Health in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tepezza Covered by Aetna CVS Health in Georgia Aetna covers Tepezza (teprotumumab) for thyroid eye disease under medical benefit with prior authorization requiring moderate-to-severe TED, ophthalmologist prescription, and documented steroid failures. Submit PA via Aetna provider portal with Clinical Activity Score ≥4, recent thyroid labs, and treatment

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in Ohio: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tepezza Covered by UnitedHealthcare in Ohio UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) in Ohio, with coverage limited to 8 lifetime infusions for moderate-to-severe thyroid eye disease. You'll need a Clinical Activity Score (CAS) ≥3, euthyroid thyroid labs, and documented steroid failure or contraindication. Submit

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Tepezza Covered by UnitedHealthcare in New York UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) with specific criteria: moderate-to-severe thyroid eye disease (CAS ≥3), euthyroid status, and documented steroid failure or contraindication. Submit through the UHC Provider Portal with complete documentation including Clinical Activity Score, thyroid labs, and

How to Get Tepezza (Teprotumumab) Covered by UnitedHealthcare in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Tepezza Coverage with UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Tepezza (teprotumumab) in New Jersey for moderate-to-severe thyroid eye disease. Your ophthalmologist or endocrinologist must submit documentation showing Clinical Activity Score ≥3, euthyroid status, and failed corticosteroid treatment via the UHC Provider Portal. If denied, New

Myths vs. Facts: Getting Tepezza (teprotumumab) Covered by Humana in New Jersey

Answer Box: Tepezza Coverage Facts for New Jersey Humana Members Myth-busting reality: Tepezza (teprotumumab) requires prior authorization through Humana Medicare Advantage in New Jersey, but approval is possible with proper documentation. Key facts: Submit PA via Humana Clinical Pharmacy Review (800-555-2546), include Clinical Activity Score ≥4, thyroid labs ≤30 days,

How to Get Tepezza (teprotumumab) Covered by Humana in Georgia: Complete Prior Authorization and Appeals Guide

Quick Answer: Humana requires prior authorization for Tepezza (teprotumumab) for thyroid eye disease in Georgia. Submit your PA request through CoverMyMeds or Humana's provider portal with complete TED documentation: CAS score ≥4, thyroid labs within 30 days, prior therapy history, and ophthalmology notes. If denied, appeal within 65

Renewing Tepezza (Teprotumumab) Approval with Aetna CVS Health in New York: Complete Guide to Documentation and Timelines

Answer Box: Renewing Tepezza Coverage Most Aetna CVS Health plans limit Tepezza to one 8-infusion course per lifetime. Renewal beyond 8 doses requires exceptional documentation showing unmet clinical need plus peer-reviewed evidence supporting extended treatment. Start renewal requests 2-4 weeks before your final scheduled infusion. If denied, New York residents

How to Get Tepezza (Teprotumumab) Covered by Cigna in Virginia: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Tepezza Approved by Cigna in Virginia Cigna requires prior authorization for Tepezza (teprotumumab) in Virginia. Your fastest path: Have your ophthalmologist or endocrinologist submit a PA request with documented moderate-to-severe thyroid eye disease (TED), including objective measurements and functional impact. If denied, you have 180 days to